Bixby Bridge Fund III LLC 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-27 5:11 pm Purchase |
2021-06-30 | 13G | Akari Therapeutics, Plc AKTX |
Bixby Bridge Fund III LLC | 2,022 9.440% |
2,022 (New Position) |
Filing |